Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jayhawk Fine Chemicals is a U.S.-based fine chemical manufacturer focused on custom manufacturing, chemical intermediates, active ingredients, specialty products, and anhydrides. The company serves pharmaceutical and life-science customers alongside agrochemical, aerospace, electronics, semiconductor, and specialty materials markets. Its capabilities span advanced chemistry, process development, cGMP-compliant manufacturing, and scale-up from laboratory through pilot and commercial production. Jayhawk is headquartered in Galena, Kansas and operates a large U.S. manufacturing site with decades of operating history. The company was acquired by Anupam Rasayan following a sale process initiated by CABB in late 2025 and completed in early 2026.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jayhawk Fine Chemicals.